Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, March 2, 2023 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such, which are hereby reported in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523.
The transactions concern the award of restricted stock units (RSUs) including matching shares to members of the Company’s Executive Management in accordance with a decision today by the Board of Directors to defer 50% of the annual cash bonus related to Executive Management’s performance in 2022 by conversion into RSUs. The RSUs and matching shares will vest in three years from the date of grant, provided that all vesting conditions have been met.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Paul Chaplin | |
| 2. | Reason for the notification | ||
| a) | Position/status | President and Chief Executive Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 151.55 | 10,642 | ||
| d) | Aggregated information
| 10,642 DKK 1,612,821.00 | |
| e) | Date of the transaction | 2023-03-02 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Henrik Juuel | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Financial Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 151.54 | 5,748 | ||
| d) | Aggregated information
| 5,748 DKK 871,062.00 | |
| e) | Date of the transaction | 2023-03-02 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Jean-Christophe May | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Commercial Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 151.53 | 5,184 | ||
| d) | Aggregated information
| 5,184 DKK 785,551.00 | |
| e) | Date of the transaction | 2023-03-02 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Laurence De Moerlooze | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Medical Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 151.59 | 4,981 | ||
| d) | Aggregated information
| 4,981 DKK 755,057.00 | |
| e) | Date of the transaction | 2023-03-02 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Anu Helena Kerns | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief People Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 151.52 | 3,450 | ||
| d) | Aggregated information
| 3,450 DKK 552,750.00 | |
| e) | Date of the transaction | 2023-03-02 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Russell Thirsk | |
| 2. | Reason for the notification | ||
| a) | Position/status | Executive Vice President and Chief Operating Officer of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Restricted Stock Units DK0015998017 | |
| b) | Nature of the transaction | Grant | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 151.57 | 3,637 | ||
| d) | Aggregated information
| 3,637 DKK 551,250.00 | |
| e) | Date of the transaction | 2023-03-02 | |
| f) | Place of the transaction | Outside a trading venue | |
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the research and development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance public health preparedness. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, and in-licensed technologies, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including Phase 3 development programs for an RSV vaccine for older adults and a next-generation COVID-19 vaccine. For more information visit www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, graham@paddockcircle.com, Tel: +1 781 686 9600
Company Announcement no. 09 / 2023
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
ALK upgrades its full-year revenue outlook2.5.2024 19:26:00 CEST | Press release
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the 2024 full-year financial outlook has been updated. Revenue is now expected to grow by 10-13% in local currencies (previously: 9-12%). The full-year financial outlook has been updated mainly to reflect the recent development in European tablet sales. The EBIT margin is still expected to improve to 17-19% but the earnings outlook now includes one-off costs of approximately DKK 60 million related to optimization initiatives, whereas no such costs were included in the original outlook from February 8, 2024. ALK has decided to advance the release of its first quarter results. The Q1 report, originally due for 3 May 2024, will be published today, 2 May 2024. The previously announced presentation for investors and analysts will still take place on 3 May 2024 at 12:30 CET. ALK-Abelló A/S For further information please contact: Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525 Media: Maiken Riise Andersen, tel
ALK opjusterer sine forventninger til salget for helåret2.5.2024 19:26:00 CEST | pressemeddelelse
ALK opjusterer sine salgsforventninger for helåret ALK (ALKB:DC / OMX: ALK B / AKBLF) annoncerede i dag, at salgsforventningerne for helåret 2024 er blevet opjusteret. Omsætningen forventes nu at vokse med 10-13% i lokale valutaer (tidligere: 9-12%), primært for at afspejle den seneste udvikling inden for salg af tabletter i Europa. EBIT-marginen forventes stadig at forbedres til 17-19%, men resultatprognosen inkluderer nu engangsomkostninger på cirka 60 millioner DKK relateret til optimeringsinitiativer. Disse omkostninger ikke var inkluderet i den oprindelige prognose fra den 8. februar 2024. ALK har besluttet at fremskynde offentliggørelsen af delårsrapporten for første kvartal. Rapporten, der oprindeligt skulle offentliggøres den 3. maj 2024, vil i stedet blive offentliggjort i dag, den 2. maj 2024. Præsentationen for investorer og analytikere, som tidligere annonceret, vil stadig finde sted den 3. maj 2024 kl. 12:30 CEST. ALK-Abelló A/S For yderligere oplysninger kontakt venligs
Orange Belgium completes its capital increase by contribution in kind – Nethys exchanges its stake in VOO Holding for newly issued shares of Orange Belgium2.5.2024 19:00:00 CEST | Press release
Press release Brussels, 2 May 2024 Regulated information – Inside information Orange Belgium completes its capital increase by contribution in kind – Nethys exchanges its stake in VOO Holding for newly issued shares of Orange Belgium On 2 May 2024, the shareholders’ meeting of Orange Belgium SA (the “Company”) approved the contribution in kind by Nethys SA (“Nethys”) of its 25% (+ 1 share) stake in VOO Holding SA (“VOO Holding”) to the capital of the Company in exchange for newly issued shares of the Company. Following the capital increase, Nethys holds a total of 7,467,448 shares in the Company, representing 11.08% of the share capital. In application of Article 15 of the Law of 2 May 2007 on the disclosure of major shareholdings in issuers whose shares are admitted for trading on a regulated market, the Company publishes, by means of a press release and on its website, (i) the total share capital, (ii) the total number of securities with voting rights and (iii) the total number of vo
Adevinta ASA (ADE) - Mandatory notification of trade – Employee Share Purchase Plan2.5.2024 19:00:00 CEST | Press release
Oslo, 2nd May 2024 - Employees of Adevinta ASA have on the 30 of April 2024 purchased 82,975 Adevinta shares through a broker on the Oslo Stock Exchange as part of Adevinta’s employee share purchase plans at an average share price of NOK 113.46 per share. The shares will be transferred to the participants in the coming days. The transactions are related to the 1st enrollment window in the Adevinta Share Purchase Plan for 2024, and based on savings made during January, February and March 2024. The transactions included primary insiders in Adevinta ASA. The notifications of the transaction are attached to this press release in accordance with MAR regulation. The purpose of Adevinta’s employee share purchase plan is to motivate and retain employees as well as to increase the interest in Adevinta’s result and performance through owning Adevinta shares. After two years of ownership, the company will allocate one bonus share for every share bought in connection with this offer. For more info
AB Traction: Kommuniké från AB Tractions årsstämma och konstituerande styrelsemöte den 2 maj 20242.5.2024 19:00:00 CEST | Pressemelding
Kommuniké från AB Tractions årsstämma och konstituerande styrelsemöte den 2 maj 2024 Vid årsstämman i AB Traction och efterföljande konstituerande styrelsemöte beslutades följande: Resultaträkningen och balansräkningen samt koncernresultaträkningen och koncernbalansräkningen för 2023 fastställdes. Styrelseledamöterna samt verkställande direktören beviljades ansvarsfrihet för förvaltningen under verksamhetsåret 2023. Utdelning till aktieägarna beslutades att lämnas med 10,45 kronor per aktie (totalt 155 Mkr) i enlighet med styrelsens förslag. Avstämningsdag för rätt att erhålla utdelning fastställdes till måndagen den 6 maj 2024 och utdelning till aktieägarna beräknas ske fredagen den 10 maj 2024. Arvode till styrelsen fastställdes till 280 000 kronor, att fördelas med 140 000 kronor var till de två av årsstämman valda styrelseledamöterna som inte är anställda i bolaget. Inget arvode utgår till styrelsens ordförande. Till styrelseledamöter omvaldes Henrik Lange, Jonas Olavi, Bengt Still